Industrial Alliance Investment Management’s Ascendis Pharma A/S ASND Stock Holding History

Industrial Alliance Investment Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,428	Closed	-$419K	–	522
2022 Q4	$419K	Hold	3,428	–	–	0.01%	298
2022 Q3	$354K	Hold	3,428	–	–	0.01%	306
2022 Q2	$319K	Sell	3,428 -269	-7%	-$25.4K	0.01%	316
2022 Q1	$434K	Hold	3,697	–	–	0.01%	316
2021 Q4	$497K	Buy	+3,697	New	+$550K	0.01%	306

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Industrial Alliance Investment Management's ASND Position: Q1 2023 in Review

Industrial Alliance Investment Management sold out of Ascendis Pharma A/S (ASND) in Q1 2023, closing a stake of 3,428 shares — an estimated $419K sold.

Industrial Alliance Investment Management first reported a position in ASND in Q4 2021 and held it in 5 quarters. The position peaked at $497K in Q4 2021. 164 funds tracked by Wall St. Rank hold ASND as of Q1 2023.

Industrial Alliance Investment Management reported no remaining Ascendis Pharma A/S position as of Q1 2023 after selling out during the quarter.
Industrial Alliance Investment Management sold 3,428 Ascendis Pharma A/S shares in Q1 2023, an estimated $419K.
Industrial Alliance Investment Management first reported a position in Ascendis Pharma A/S in Q4 2021 and held it in 5 quarters.
Industrial Alliance Investment Management's Ascendis Pharma A/S position peaked at $497K in Q4 2021.
164 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2023.

Based on Industrial Alliance Investment Management's 13F filing for Q1 2023, filed 11 May 2023.